We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$640M
AUM Growth
+$42M
Cap. Flow
-$15.9M
Cap. Flow %
-2.48%
Top 10 Hldgs %
39.6%
Holding
108
New
27
Increased
17
Reduced
24
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 57.26%
2 Miscellaneous 29.95%
3 Technology 9.65%
4 Consumer Discretionary 2.53%
5 Utilities 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLI icon
101
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
-57,700
Closed -$5.84M
RETA
102
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-7,689
Closed -$699K
KDNY
103
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-92,200
Closed -$2.13M
OTMO
104
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
-26,124
Closed -$186K
BLU
105
DELISTED
BELLUS Health Inc.
BLU
-799,860
Closed -$5.76M
ONCR
106
DELISTED
Oncorus, Inc.
ONCR
-540,258
Closed -$186K

Similar funds

Sphera Funds Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sphera Funds Management held 108 positions worth $640M, up 7% from $598M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sphera Funds Management's Q2 2023 filing shows 27 new, 17 increased, 24 reduced and 21 closed positions. Its largest new stake was Praxis Precision Medicines: 584,289 shares worth $10.1M. The largest sale was Nutrien, an estimated $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Miscellaneous and Technology.

  • Sphera Funds Management's largest Q2 2023 buy was Praxis Precision Medicines: 584,289 shares worth $10.1M.
  • Sphera Funds Management added most to Amazon in Q2 2023, an estimated $4.41M increase.
  • Sphera Funds Management's biggest Q2 2023 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $8.02M.
  • Sphera Funds Management fully exited Nutrien in Q2 2023, selling an estimated $10.7M.
  • Sphera Funds Management's ten largest holdings make up 40% of its $640M portfolio in Q2 2023.
  • Sphera Funds Management opened 27 new positions and closed 21 in Q2 2023.
  • Sphera Funds Management's portfolio value rose 7% quarter-over-quarter to $640M.

Based on Sphera Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.